Summit Financial’s Chemours CC Stock Holding History

Summit Financial’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-25,995	Closed	-$298K	–	1242
2025 Q2	$298K	Buy	+25,995	New	+$293K	0.01%	683

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Summit Financial's CC Position: Q3 2025 in Review

Summit Financial sold out of Chemours (CC) in Q3 2025, closing a stake of 25,995 shares — an estimated $298K sold.

Summit Financial first reported a position in CC in Q2 2025 and held it in 1 quarter. The position peaked at $298K in Q2 2025. 428 funds tracked by Wall St. Rank hold CC as of Q3 2025.

Summit Financial reported no remaining Chemours position as of Q3 2025 after selling out during the quarter.
Summit Financial sold 25,995 Chemours shares in Q3 2025, an estimated $298K.
Summit Financial first reported a position in Chemours in Q2 2025 and held it in 1 quarter.
Summit Financial's Chemours position peaked at $298K in Q2 2025.
428 funds tracked by Wall St. Rank held Chemours as of Q3 2025.

Based on Summit Financial's 13F filing for Q3 2025, filed 14 Nov 2025.